2-(3-Bromopyridin-4-yl)acetonitrile

Catalog No. :
ACTZLY349
CAS No. :
142892-31-7
Molecular Formula :
C7H5BrN2
Molecular Weight :
197.04

IUPAC Name:2-(3-bromopyridin-4-yl)acetonitrile

2-(3-Bromopyridin-4-yl)acetonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$65.00Login to see priceIn stockIn stock
250mg98%$102.00Login to see priceIn stockIn stock
1g98%$211.00Login to see priceIn stockIn stock
5g98%$1023.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Bromopyridin-4-yl)acetonitrile
IUPAC Name2-(3-bromopyridin-4-yl)acetonitrile
MDL No.MFCD10000070
Molecular FormulaC7H5BrN2
Molecular Weight197.04
SMILESN#CCC1=C(Br)C=NC=C1
InChI KeyXAOBSLPTEJADHP-UHFFFAOYSA-N
Synonym2-(3-BROMOPYRIDIN-4-YL)ACETONITRILE | 142892-31-7 | 4-Pyridineacetonitrile, 3-bromo- | 3-Bromopyridine-4-acetonitrile | SCHEMBL360235 | DTXSID90571890 | (3-Bromopyridin-4-yl)acetonitrile | AKOS006302635 | DS-9628 | SB53224 | CS-0186400 | C72683 | EN300-1898376 | A885085
CAS No.142892-31-7
PubChem CID15353734

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTZLY349 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACTZLY349 route product structure diagram
    ACTZLY349142892-31-7 In Stock
Inquiry

2. ACTZLY349 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACTZLY349 route product structure diagram
    ACTZLY349142892-31-7 In Stock
Inquiry

Comments (0)